Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Apple, Kellogg And 3 Stocks To Watch Heading Into Thursday

With US stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:
byLisa Levin
May 4, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

With US stock futures trading lower this morning on Thursday, some of the stocks that may grab investor focus today are as follows:

  • Wall Street expects Kellogg Company (NYSE:K) to post quarterly earnings at $0.99 per share on revenue of $3.95 billion before the opening bell. Kellogg shares rose 0.5% to close at $71.53 on Wednesday.
  • QUALCOMM Incorporated (NASDAQ:QCOM) reported better-than-expected sales results for its second quarter, but issued weak Q3 guidance. QUALCOMM shares dropped 6.6% to $105.41 in the after-hours trading session.
  • Analysts are expecting Apple Inc. (NASDAQ:AAPL) to have earned $1.43 per share on revenue of $92.98 billion for the latest quarter. The company will release earnings after the markets close. Apple shares fell 1.1% to $165.60 in after-hours trading.

Check out our premarket coverage here

  • Etsy, Inc. (NASDAQ:ETSY) reported stronger-than-expected sales for its first quarter. Etsy shares gained 4.1% to $102.97 in the after-hours trading session.
  • Analysts expect PG&E Corporation (NYSE:PCG) to post quarterly earnings at $0.30 per share on revenue of $5.86 billion before the opening bell. PG&E shares fell 0.5% to $17.20 in after-hours trading.

Read This Next: Over $2M Bet On Vivani Medical? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

MaxCyte Signed Strategic Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment of Rare Intractable Diseases

By Charles Gross
December 5, 5:51 AM
MaxCyte, Inc., (NASDAQ:MXCT, LSE: MXCT))), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, and Curamys, a South Korean biotechnology company that develops cell & gene therapy using cell fusion technology to treat

MXCT

Read More

Why SunPower Stock Is Down Today

By Erica Kollmann
February 16, 5:00 PM
On Thursday, SunPower announced fourth-quarter losses of 51 cents per share which missed the analyst consensus estimate of losses of 24 cents by 112.5%. The company reported quarterly sales of $361.3 million, missing the analyst consensus estimate of $362.85 million and respresting a 27.35% decrease over sales of $497.31 million from the same period last year.

SPWR